Manuela Hogie is currently the Head of vivo DMPK at Oncodesign, where they have been building teams and leading lab operations for DMPK vivo studies since 2018. Prior to this role, Manuela gained extensive experience as a Scientist at Abbott, where they specialized in cardiovascular and diabetes research, and worked as a DMPK Scientist at Solvay Pharmaceuticals. Their career began at Sanofi-Synthelabo as a Cardiovascular Pharmacologist. Manuela has also served as a Clinical Research & Pharmacovigilance Officer at For Drug Consulting, focusing on clinical study design and pharmacovigilance. They hold a PhD in biological and medical sciences from Université de Rouen and multiple degrees from various institutions, including a DEA in Toxicology from Université de Metz.
This person is not in the org chart
This person is not in any teams
This person is not in any offices